Medicare Enrolled
Dr. Chad Metzger, D.O.
Interventional Pain Medicine Physician · Darby, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Metzger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Metzger?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Metzger
Dr. Chad Metzger is an interventional pain medicine physician in Darby, PA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Metzger performed 7,110 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Metzger received a total of $12,692 from 31 pharmaceutical and/or device companies across 337 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Metzger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 6% volume in PA
$12,692 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,110
Medicare services
Top 6% in PA for interventional pain medicine physician
Not available
Unique patients (not deduplicated)
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
1,546 | $4 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,422 | $104 | $652 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,400 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
540 | $0 | $2 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
364 | $61 | $300 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
249 | $53 | $205 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $72 | $462 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
152 | $138 | $844 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
140 | $242 | $1,000 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
138 | $153 | $780 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
128 | $209 | $928 |
| Contrast dye for imaging, lower concentration | 95 | $0 | $3 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
90 | $215 | $1,708 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
86 | $112 | $575 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
85 | $219 | $1,407 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
85 | $111 | $901 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
64 | $381 | $2,214 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
59 | $797 | $5,750 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
40 | $244 | $1,700 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
40 | $98 | $610 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
40 | $5 | $36 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
39 | $158 | $1,109 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
37 | $64 | $432 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
27 | $40 | $199 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
24 | $96 | $583 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
23 | $225 | $1,425 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
21 | $206 | $1,599 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
21 | $107 | $799 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,692
Total received (2018-2024)
Avg $2,115/year across 6 years
Top 8% in PA for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
337
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,815
2023
$2,788
2022
$4,706
2021
$3,131
2020
$241
2018
$11
Payments by company (2024)
Abbott Laboratories
$520
Vertos Medical, Inc.
$379
Boston Scientific Corporation
$308
SCILEX PHARMACEUTICALS INC.
$156
Nevro Corp.
$127
SI-BONE, INC.
$80
IBSA Pharma Inc.
$72
PAINTEQ LLC
$54
Valinor Pharma, LLC
$46
Collegium Pharmaceutical, Inc.
$38
ABBVIE INC.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,889
Abbott Laboratories
$2,544
MML US, Inc.
$2,129
Boston Scientific Corporation
$1,177
Nevro Corp.
$875
Vertos Medical, Inc.
$764
Collegium Pharmaceutical, Inc.
$387
Scilex Pharmaceuticals Inc.
$338
Medtronic USA, Inc.
$195
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$184
PAINTEQ LLC
$161
SCILEX PHARMACEUTICALS INC.
$156
ABBVIE INC.
$142
Foundation Fusion Solutions, LLC
$90
SI-BONE, INC.
$80
IBSA Pharma Inc.
$72
Valinor Pharma, LLC
$71
SPR Therapeutics, Inc
$66
Averitas Pharma Inc.
$59
Lilly USA, LLC
$57
FORTE BIO-PHARMA LLC
$36
GRT US Holding, Inc.
$34
Stimwave Technologies Incorporated
$34
Axsome Therapeutics, Inc.
$32
Forte Bio-Pharma LLC
$29
Almatica Pharma LLC
$20
Alnylam Pharmaceuticals Inc.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$18
Currax Pharmaceuticals LLC
$13
Kowa Pharmaceuticals America, Inc.
$12
Daiichi Sankyo Inc.
$11
Top 3 companies account for 59.6% of all-time payments
Associated products mentioned in payments ›
BOTOX · Belbuca · ELEVATE · EMGALITY · ETERNA · GIVLAARI · GRALISE · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · MOVANTIK · Morphabond ER · NURTEC ODT · OCTRODE · ONZETRA XSAIL · Omnia · PAINTEQ · PENTA · PROCLAIM · PROLATE · QULIPTA · QUTENZA · Qutenza · RELISTOR · ReActiv8 · SPECIFY · SPRINT PNS System · SYNCHROMED · Seglentis · Senza · StimQ Receiver Stimulator Kit Channel A US w Receiver · Sunosi · Superion Indirect Decompression System · Tirosint · UBRELVY · VANTA ADAPTIVESTIM · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Interventional pain medicine physicians in nearby ZIP areas
17
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
MERCY CATHOLIC MEDICAL CENTER- MERCY FITZGERALD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Metzger is a clinical cardiology specialist, with above-average Medicare volume (top 6% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Metzger experienced with assessment of emotional or behavioral problems?
Based on Medicare claims data, Dr. Metzger performed 1,546 assessment of emotional or behavioral problems services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Metzger receive payments from pharmaceutical companies?
Yes. Dr. Metzger received a total of $12,692 from 31 companies across 337 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Metzger's costs compare to other interventional pain medicine physicians in Darby?
Dr. Metzger's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Metzger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Darby
Browse interventional pain medicine physicians in Darby ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in PA
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in PA
Which PA interventional pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
MML US, Inc. Payments to Doctors
See all physicians who received payments from MML US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology